Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma
Status:
Recruiting
Trial end date:
2026-07-31
Target enrollment:
Participant gender:
Summary
There is no clinical study on epidermal growth factor receptor tyrosine kinase inhibitors has
been systematically conducted in adenoid cystic carcinoma.
This is a phase II study EGFR TKIs in adenoid cystic carcinoma to evaluate its efficacy in
this disease.